Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors

New research in JNCCN finds that only 30% of patients with advanced neuroendocrine tumors (NETs) say their top goal for treatment is living longer. Only 51.7% of patients perceived that they had the same treatment goals as their physician.